On-demand release of encapsulated ZnO nanoparticles and chemotherapeutics for drug delivery applications.

RSC Pharm · 2025 · PMC11650639 · PMID 39703205

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

While this is consistent with studies that report that lipid carriers for PTX have similar cell viability profiles to using “free” PTX, 53,54 the triggered release groups (green) showed a trend of improved efficacy.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.